LCE is a branch of the Lymphoma Coalition, with an autonomous budget and a dedicated bank account. LCE’s relationships with its sponsors and supporters are regulated by LC policies on Funding Agreements and Transparency. LC and LCE accounts are reviewed on a yearly basis by a statutory auditor.
In the financial years ending 30 April 2017 and 2018, LCE has received funding from the following companies:
- Bristol-Myers Squibb
For further information on LCE’s funding sources and activities click on the links below: